Protai Leverages NVIDIA NIM and AlphaFold for Enhanced Protein Structure Prediction

In a significant advancement for the field of drug discovery, Protai, a member of the NVIDIA Inception program, is utilizing cutting-edge technologies to enhance protein structure predictions. By integrating breakthroughs like AlphaFold and NVIDIA NIM microservices, Protai aims to revolutionize how biotech firms and research institutions approach the study of protein structures, according to NVIDIA.

Innovative Approach to Protein Structure Prediction

Protai’s platform leverages Mass Spectrometry Proteomics alongside generative AI models to develop precision medicine solutions. This integration is pivotal in capturing the structural changes among different protein states, thereby facilitating more accurate predictions for specific mechanisms of action. The company’s approach goes beyond single protein conformations, focusing instead on the dynamic nature of proteins which can assume multiple forms depending on environmental factors.

Enhancing Predictions with NVIDIA NIM

To accelerate AI inferencing, Protai has adopted NVIDIA NIM microservices. These services are designed for optimized generative AI biology models, enabling Protai to achieve higher throughput and reduced latency in protein structure predictions. This technological synergy allows Protai to make significant strides in drug discovery by providing accurate and scalable predictions.

Case Study: H3-H4 Protein Complex

Protai’s capabilities were exemplified in their work on predicting the structure of the H3-H4 protein complex, crucial for DNA accessibility and stability. Using AlphaFold2-Multimer NIM, Protai generated a structural prediction that visually represented confidence levels. The integration of cross-linking mass spectrometry (XL-MS) data further refined these predictions, offering experimental anchors that validate or reveal new potential protein states.

Scalable Deployment with NVIDIA NIM

Protai’s deployment of AlphaFold-Multimer with NVIDIA NIM allows for scalable and optimized predictions, essential for handling the complex nature of protein interactions. The use of NVIDIA’s preoptimized inference containers ensures top-tier performance, whether on-premises or in cloud environments. This setup facilitates parallel processing of multiple protein complexes, significantly reducing prediction time, especially for large complexes.

Protai’s innovative workflow, which combines structural prediction with unique experimental data, exemplifies the potential of AI in advancing drug discovery. By leveraging NVIDIA’s AI infrastructure, Protai has opened new frontiers in precision medicine, enhancing our understanding of protein interactions and their implications for therapeutic development.

For more information, visit the NVIDIA blog.

Image source: Shutterstock